Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
229 words
IN THE PROCESS FOR PREPARING A 2'''' DEOXY-3'''' -DESAMINO2'''',3'''' -EPIMINO-4,6-DI-(AMINOGLYCOSYL)-2-DEOXYSTREPTAMMINE WHEREIN AN ANTIBACTERIALLY ACTIVE 4,6-DI (AMINOGLYCOSYL) -25DEOXYSTREPTAMINE HAVING A 2'''' -HYDROXY FUNCTION AND A 3''''PRIMARY OR SECONDARY AMINO FUNCTION, THE PRIMARY AND SECONDARY AMINO GROUPS OF WHICH ARE PROCTED BY CARBOBENZYLOXY GROUPS AND PRIMARY AND SECONDARY HYDROXYL GROUPS OF WHICH ARE CONVERTED TO A TRIPHENYLMETHYL ETHER OFA PRIMARY HYDROXYL GROUP OR ACYCLIC KETAL OR ACETAL OF PROTECTABLE NEIGHBORING HYDROXYL GROUPS, IS TREATED WITH A HYDROCARBONSULFONYL HALIDE IN ATERIARY AMINE, THE THEREBY FORMED 2'''' -OHYDROCARBONSULFONY-2-N-CARBOBENZYLOXY 4,6-DI-( (AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE IS TREATED WITH HYDROGEN IN THE PRESENCE OF A CATALYST, OR WITH AN ALKALI METAL IN LIQUID AMMONIA, WHEREBY THE N-CARBBOBENZYLOZY GROUPS ARE REMOVED; AND THE RESULTING 2'''' -O-HYDROCARBONSULFONYL 4,6-DI-( AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE IS CONVERTED TO A 2''''DEOXY-3''''-DESAMINO-2'''',3''''-EPIMINO 4,6-DI(AMINOGLYCOSYL)2-DEOXYSTREPTAMINE BY SPONTANEOUS TRANSFORMATION OR BY HEATING IN A LOWER ALKANOL ALONE OR TOGETHER WITH AN ALKALI METAL SALT OF SAID ALKANOL; THE IMPROVEMENT WHICH COMPRISES PROTECTING PRIMARY AMINO GROUPS AND SECONDARY AMINO GROUPS CAPABLE OF OXAZOLIDINE FORMATION WITH AN ALDEHYDE AND A NEIGHBORING HYDROXYL GROUP M SAID ANTIBACTERIAL ACTIVE 4,6-DI(AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE BY SCHIFF BASEOXAZOLIDINE CONDENSATION PRODUCTS WITH AN ALDEHYDE DEVOID OF HYDROXYL GROUPS; AND, AFTER PREPARATION OF THE 2''''-O-HYDROCARBONSULFONYL ESTER THEREOF, TREATING THE RESULTING 2''''-O-HYDROCARBONSULFONYL 4,6-DI(AMINOGLYCOSYL)-2- DEOXYSTREPTAMINE HAVING NPROCTECTING-SCHIFF BASE -OXAZOLIDINE GROUPS WITH DILUTE AQUEOUS ACID TO A PH IN THE RANGE OF FROM ABOUT 1 TO ABOUT 5, WHEREBY SAID N-PROTECTING SCHIFF BASEOXAZOLIDINE GROUPS ARE REMOVED.
Claim 2
Dependent Claim
229 words
IN THE PROCESS FOR PREPARING A 2'''' DEOXY-3'''' -DESAMINO2'''',3'''' -EPIMINO-4,6-DI-(AMINOGLYCOSYL)-2-DEOXYSTREPTAMMINE WHEREIN AN ANTIBACTERIALLY ACTIVE 4,6-DI (AMINOGLYCOSYL) -25DEOXYSTREPTAMINE HAVING A 2'''' -HYDROXY FUNCTION AND A 3''''PRIMARY OR SECONDARY AMINO FUNCTION, THE PRIMARY AND SECONDARY AMINO GROUPS OF WHICH ARE PROCTED BY CARBOBENZYLOXY GROUPS AND PRIMARY AND SECONDARY HYDROXYL GROUPS OF WHICH ARE CONVERTED TO A TRIPHENYLMETHYL ETHER OFA PRIMARY HYDROXYL GROUP OR ACYCLIC KETAL OR ACETAL OF PROTECTABLE NEIGHBORING HYDROXYL GROUPS, IS TREATED WITH A HYDROCARBONSULFONYL HALIDE IN ATERIARY AMINE, THE THEREBY FORMED 2'''' -OHYDROCARBONSULFONY-2-N-CARBOBENZYLOXY 4,6-DI-( (AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE IS TREATED WITH HYDROGEN IN THE PRESENCE OF A CATALYST, OR WITH AN ALKALI METAL IN LIQUID AMMONIA, WHEREBY THE N-CARBBOBENZYLOZY GROUPS ARE REMOVED; AND THE RESULTING 2'''' -O-HYDROCARBONSULFONYL 4,6-DI-( AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE IS CONVERTED TO A 2''''DEOXY-3''''-DESAMINO-2'''',3''''-EPIMINO 4,6-DI(AMINOGLYCOSYL)2-DEOXYSTREPTAMINE BY SPONTANEOUS TRANSFORMATION OR BY HEATING IN A LOWER ALKANOL ALONE OR TOGETHER WITH AN ALKALI METAL SALT OF SAID ALKANOL; THE IMPROVEMENT WHICH COMPRISES PROTECTING PRIMARY AMINO GROUPS AND SECONDARY AMINO GROUPS CAPABLE OF OXAZOLIDINE FORMATION WITH AN ALDEHYDE AND A NEIGHBORING HYDROXYL GROUP M SAID ANTIBACTERIAL ACTIVE 4,6-DI(AMINOGLYCOSYL)-2-DEOXYSTREPTAMINE BY SCHIFF BASEOXAZOLIDINE CONDENSATION PRODUCTS WITH AN ALDEHYDE DEVOID OF HYDROXYL GROUPS; AND, AFTER PREPARATION OF THE 2''''-O-HYDROCARBONSULFONYL ESTER THEREOF, TREATING THE RESULTING 2''''-O-HYDROCARBONSULFONYL 4,6-DI(AMINOGLYCOSYL)-2- DEOXYSTREPTAMINE HAVING NPROCTECTING-SCHIFF BASE -OXAZOLIDINE GROUPS WITH DILUTE AQUEOUS ACID TO A PH IN THE RANGE OF FROM ABOUT 1 TO ABOUT 5, WHEREBY SAID N-PROTECTING SCHIFF BASEOXAZOLIDINE GROUPS ARE REMOVED.
Claim 3
Dependent Claim
14 words
The process of claim 1 including the step of isolating the product thereby formed.
Claim 4
Dependent Claim
35 words
The process of claim 1 wherein the N-protecting Schiff base-oxazolidine groups of said 4,6-di-(aminoglycosyl)-2-deoxystreptamine are derived from benzaldehyde, and the dilute aqueous acid treatment of said 2''''-O-hydrocarbonsulfonyl ester is carried out with dilute hydrochloric acid.
Claim 5
Dependent Claim
14 words
The process of claim 3 including the step of isolating the product thereby formed.
Claim 6
Dependent Claim
62 words
The process according to claim 1 wherein said antibacterially active 4,6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxy function and a 3''''-primary or secondary amino function is a member selected from the group consisting of gentamicin B, gentamicin B1 , gentamicin C1a, gentamicin C2, gentamicin C2a, gentamicin X2 and mixtures of the foregoing, sisomicin, verdamicin, robramycin, 3'', 4''-dideoxykanamycin B, Antibiotic JI-20A, Antibiotic JI-20B and Antibiotic G-418.
Claim 7
Dependent Claim
40 words
The process of claim 1 wherein said antibacterially active 4, 6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxyl function and a 3''''-primary or secondary amino function is a member selected from the grup consisting of genTamicin C1a, gentamicin C2, gentamicin C2a, verdamicin and sisomicin.
Claim 8
Dependent Claim
88 words
The process according to claim 1 wherein said antibacterially active 4,6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxy function and a 3''''-primary or secondary amino function is a member selected from the group consisting of gentamicin B, gentamicin B1, gentamicin C1a, gentamicin C2, gentamicin C2a, gentamicin X2 and mixtures of the foregoing, sisomicin, verdamicin, tobramycin, 3''4,''-dideoxykanamycin B, Antibiotic JI-20A, Antibiotic JI-20B and Antibiotic G-418, wherein the N-protecting Schiff base-oxazolidine groups are derived form benzaldehyde, and wherein the dilute aqueous acid treatment of said 2''''-O-hydrocarbonsulfonyl ester is carried out with dilute hydrochloric acid.
Claim 9
Dependent Claim
70 words
The process according to claim 1 wherein said antibacterially active 4,6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxy function and a 3''''-primary or secondary amino function is a member selected from the group consisting of gentamicin C1a , gentamicin C2 , gentamicin C2a, verdamicin and sisomicin, wherein the N-protecting -Schiff base-oxazolidine groups are derived from benzaldehyde, and wherein the dilute aqueous acid treatment of said 2''''-O-hydrocarbonsulfonyl ester is carried out with dilute hydrochloric acid.
Claim 10
Dependent Claim
85 words
The process of claim 1 wherein said 4,6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxy function and a 3''''-primary or secondary amino function is gentamicin C2 , wherein the N-protecting-Schiff base-oxazolidine groups are derived from benzaldehyde, wherein the hydrocarbonsulfonyl halide in a tertiary amine is methanesulfonyl chloride in pyridine, and wherein the dilute aqueous acid treatment is carried out in dilute hydrochloric acid, said process comprising treating 1,3,2, 6''-tetra-N-benzylidene-3'''', 4''''-N,O- benzylidene-gentamicin C2 with methanesulfonyl chloride in pyridine and treating the thereby formed 2''''-O-methanesulfonyl-1,3,2,'',6''-tetra-N-benzylidene-3'''', 4''''-N,O-benzylidene-gentamicin C2 with dilute hydrochloric acid.
Claim 11
Dependent Claim
15 words
The process of claim 9 including the step of isolating the 2''''-deoxy-3''''-desmethylamino-2'''',3''''-N-methylepiminogentamicin C2 thereby formed.
Claim 12
Dependent Claim
156 words
The process according to claim 1 wherein the N-protecting-Schiff base-oxazolidine groups of said 4,6-di-(aminoglycosyl)-2-deoxystreptamine are derived from benzaldehyde and the protectable primary and secondary hydroxyl groups of said 4,6-di-(aminoglycosyl)-2-deoxystreptamine are converted to a cyclic acetal with benzaldehyde, said improvement process comprising protecting the primary amino groups and secondary amino groups capable of oxazolidine formation with an aldehyde and a neighboring hydroxyl groups in an antibacterially active 4,6-di-(aminoglycosyl)-2-deoxystreptamine having a 2''''-hydroxyl function and a 3''''-primary or secondary amino function, by Schiff base-oxazolidine condensation products with benzaldehyde, and converting the protectable primary and secondary hydroxyl groups of said 4,6-di-(aminoglycosyl)-2-deoxystreptamine to cyclic acetals with benzaldehyde, treating said per-N-benzylidene-O-benzylidene 4,6-di-(aminoglycosyl)-2-deoxystreptamine with a hydrocarbonsulfonyl halide having up to eight carbon atoms in a tertiary amine, treating the resulting O-benzylidene-per-N-benzylidene-2''''-O-hydrocarbonsulfonyl-4,6-di -(aminoglycosyl)-2-deoxystreptamine with dilute aqueous acid to a pH in the range of from about 1 to about 5, whereby said O-benzylidene acetal groups and said N-benzylidene Schiff base oxazolidine groups are removed.
Claim 13
Dependent Claim
20 words
A compound selected from the group consisting of a 2''''-O-hydrocarbonsulfonyl derivative of the following structural formulae I(a), I(b) and I(c):
Claim 14
Dependent Claim
20 words
A compound selected from the group consisting of a 2''''-O-hydrocarbonsulfonyl derivative of the following structural formulae I(a), I(b) and I(c):
Claim 15
Dependent Claim
18 words
A compound according to claim 12, formulae I(a) and I(b) wherein M is methyl and X is benzylidene.
Claim 16
Dependent Claim
41 words
A compound according to claim 12 formula I(a) wherein M is methyl, X is benzylidene, W''2 and W''6 are -N X; R''3 and R''4 are hydrogen, R''5 is methyl; the sterochemistry at C''6 being R; said compound being 1,3,2'',6''-tetra-N-benzylidene-3'''',4''''-N,O-benzylidene-2''''-O -methanesulfonylgentamicin C2.